Article on Anagrelide
PERTH, AUSTRALIA - 29 August 2019; SUDA Pharmaceuticals Ltd (ASX:SUD), a leader in oro-mucosal drug delivery ("SUDA"). is pleased to announce that Research Outreach has released on article on SUDA's anagrelide project.
For further information please download the attached PDF:
Download this document
